ARTICLE | Financial News
Neuralstem completes private placement of convertible preferred and common stock
December 14, 2016 10:59 PM UTC
Neuralstem raised $20 million through the sale of 28.5 million shares at $0.25 and 1 million shares of series A convertible preferred stock at $12.79 in a private placement with Tianjin Pharmaceutical...
BCIQ Company Profiles